Etcelera is a drug discovery company whose Causal Intelligence engine combines evidence from human cells, patients, and computational models.
Etcelera operates as a drug discovery and development company that Flagship Pioneering created by merging the platforms of Cellarity, Etiome, and Empress Therapeutics, and its platform-derived programs span hematology, metabolism, and immunology. Each of those three platforms was originated in Flagship Labs, and Cellarity's approach reads and corrects the state of the whole cell.
Its causal biology platform combines high-resolution human transcriptomic data, advanced chemoproteomics, and large-scale perturbation data with AI-powered prediction models to determine cause and effect in disease and to define novel targets, while its multi-omic data generation capabilities discern how and why new molecules work. Etcelera works with partners on drug programs, which makes partners the audience for those programs.